Toripalimab Evidence Journey in Cancer Care

By Rene Pretorius

April 9, 2025

The FDA approved toripalimab (Loqtorzi) on October 27, 2023, as the first immunot...
Survival Benefits of Immune Checkpoint Inhibitors in Metastatic Colorectal Ca...
Enhancing Colorectal Cancer Screening Through Mail and Navigation Strategies
Deadline Boosts Colorectal Cancer Screening Uptake in TEMPO Trial
Fabhalta C3 glomerulopathy treatment Gains EMA Endorsement as First Targeted ...
Zircaix: A Potential Breakthrough in Kidney Cancer Diagnosis
Personalized Cancer Vaccine in High-Risk Kidney Cancer Patients
Advancing Cancer Treatment: Ivonescimab’s Potential and Strategic Collaborati...
Journavx Pain Management: FDA Approves New Non-Opioid Treatment for Acute Pain
Engineered Heart Muscle Allografts Show Promise in Heart Repair
Promising Results of Personalized Cancer Vaccine in Renal Cell Carcinoma
FDA Grants Datopotamab Deruxtecan Approval for HR-Positive Breast Cancer Trea...
Promising Dual Immunotherapy for Anaplastic Thyroid Cancer